Publications by authors named "Bogen Ye"

Claim this Profile
H
Hepatectomy combined with sorafenib in patients with intermediate-advanced hepatocellullar carcinoma.
Hongfei Zhu, Bogen Ye, Zhenguo Qiao, Li Zeng, Qigen Li

J BUON· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SHP-1 inhibits renal ischemia reperfusion injury via dephosphorylating ASK1 and suppressing apoptosis.
Hongzhe Tian, Rumeng Tan, Bogen Ye, Sijia Yan, Mingxing Sui

Biochem Biophys Res Commun· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High expression of S100A12 on intratumoral stroma cells indicates poor prognosis following surgical resection of hepatocellular carcinoma.
Hao Cai, Bo-Gen Ye, Jian-Yang Ao, Xiao-Dong Zhu, Yuan-Yuan Zhang

Oncol Lett· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD31 regulates metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma via the ITGB1-FAK-Akt signaling pathway.
Yuan-Yuan Zhang, Ling-Qun Kong, Xiao-Dong Zhu, Hao Cai, Cheng-Hao Wang, Bo-Gen Ye

Cancer Lett· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a.
Man-Qing Cao, A-Bin You, Xiao-Dong Zhu, Wei Zhang, Yuan-Yuan Zhang, Bo-Gen Ye

J Hematol Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a.
Man-Qing Cao, A-Bin You, Xiao-Dong Zhu, Wei Zhang, Yuan-Yuan Zhang, Bo-Gen Ye

J Hematol Oncol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colony-Stimulating Factor 1 Receptor Blockade Inhibits Tumor Growth by Altering the Polarization of Tumor-Associated Macrophages in Hepatocellular Carcinoma.
Jian-Yang Ao, Xiao-Dong Zhu, Zong-Tao Chai, Hao Cai, Yuan-Yuan Zhang, Bo-Gen Ye

Mol Cancer Ther· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flot2 promotes tumor growth and metastasis through modulating cell cycle and inducing epithelial-mesenchymal transition of hepatocellular carcinoma.
Cheng-Hao Wang, Xiao-Dong Zhu, De-Ning Ma, Hui-Chuan Sun, Dong-Mei Gao, Bo-Gen Ye

Am J Cancer Res· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colony-stimulating factor-1-induced AIF1 expression in tumor-associated macrophages enhances the progression of hepatocellular carcinoma.
Hao Cai, Xiao-Dong Zhu, Jian-Yang Ao, Bo-Gen Ye, Yuan-Yuan Zhang

Oncoimmunology· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Astragaloside IV inhibits metastasis in hepatoma cells through the suppression of epithelial-mesenchymal transition via the Akt/GSK-3β/β-catenin pathway.
Cheng-Dong Qin, De-Ning Ma, Zheng-Gang Ren, Xiao-Dong Zhu, Cheng-Hao Wang, Bo-Gen Ye

Oncol Rep· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced expression of CD109 in tumor-associated endothelial cells promotes tumor progression by paracrine interleukin-8 in hepatocellular carcinoma.
Bo-Gen Ye, Hui-Chuan Sun, Xiao-Dong Zhu, Zong-Tao Chai, Yuan-Yuan Zhang

Oncotarget· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2.
De-Ning Ma, Zong-Tao Chai, Xiao-Dong Zhu, Ning Zhang, Di-Hua Zhan, Bo-Gen Ye

J Hematol Oncol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robo1 promotes angiogenesis in hepatocellular carcinoma through the Rho family of guanosine triphosphatases' signaling pathway.
Jian-Yang Ao, Zong-Tao Chai, Yuan-Yuan Zhang, Xiao-Dong Zhu, Ling-Qun Kong, Bo-Gen Ye

Tumour Biol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
microRNA-26a suppresses recruitment of macrophages by down-regulating macrophage colony-stimulating factor expression through the PI3K/Akt pathway in hepatocellular carcinoma.
Zong-Tao Chai, Xiao-Dong Zhu, Jian-Yang Ao, Wen-Quan Wang, Dong-Mei Gao, Bo-Gen Ye

J Hematol Oncol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ischemic preconditioning provides no additive clinical value in liver resection of cirrhotic and non-cirrhotic patients under portal triad clamping: a prospective randomized controlled trial.
Bogen Ye, Hongchuan Zhao, Hui Hou, Guobin Wang, Fubao Liu

Clin Res Hepatol Gastroenterol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The value of hepatic ischemic preconditioning in hepatectomy with a prospective randomized controlled study].
Hui Hou, Xiao-ping Geng, Li-xin Zhu, Bo-gen Ye

Zhonghua Wai Ke Za Zhi· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis